Funded Startups in Westlake Village
The disclosed funding sizes in Westlake Village show one clear outlier: Velocity Financial’s $500M round (2026-01-28) dwarfs the next-largest disclosed amo…
The disclosed funding sizes in Westlake Village show one clear outlier: Velocity Financial’s $500M round (2026-01-28) dwarfs the next-largest disclosed amount, LTC’s $300M (2026-06-30), with all other disclosed rounds below $130M. The most recent disclosed activity concentrates in 2025–2026, where 7 of the 14 disclosed rows fall between 2025-03-17 (Occuspace) and 2026-06-30 (LTC). Sector concentration is visible as well: Financial Services appears multiple times (Velocity Financial in 2026-01-28 at $500M; Avinew in 2022-05-10 as undisclosed), while Biotechnology is another repeat category (Angitia Biopharmaceuticals at $130M on 2026-02-05; Genelux at $11M on 2025-03-25; A2 Biotherapeutics at $72M on 2020-10-06). Stage labeling is also mixed: “Series Unknown” occurs frequently (5 of 17 rows), alongside named Seed/Series rounds spanning from 2020-10-06 through the latest 2026-07-13 entry (Cognify, undisclosed).
Most recent rounds
17 shownRelated listings
Frequently asked
Which disclosed round is the outlier in Westlake Village, and how does it shape the rest of the distribution?
Velocity Financial’s $500M (2026-01-28) is the largest disclosed amount and is followed by LTC’s $300M (2026-06-30). Everything else with disclosed amounts stays at or below $130M, including Angitia Biopharmaceuticals’ $130M (2026-02-05), so the funding profile is heavily skewed toward these two largest rounds.
How concentrated is activity in the most recent window (last ~12–18 months) based on the listed dates?
Within the rows shown, 7 of 14 disclosed entries close between 2025-03-17 (Occuspace, $6M) and 2026-06-30 (LTC, $300M). The nondisclosed entries remain present near the top of the list as well, including Cognify on 2026-07-13 (undisclosed) and PureSpectrum on 2026-01-06 (undisclosed).
Do any sectors appear over-represented relative to one-off categories?
Financial Services repeats: Velocity Financial (2026-01-28, $500M) and Avinew (2022-05-10, undisclosed) are both categorized as Financial Services. Biotechnology also shows up multiple times—Angitia Biopharmaceuticals ($130M on 2026-02-05), Genelux ($11M on 2025-03-25), and A2 Biotherapeutics ($72M on 2020-10-06).
What does the stage mix look like, especially regarding ‘Series Unknown’?
“Series Unknown” is the most common classification across the 17 rows, appearing on 5 entries (e.g., Velocity Financial 2026-01-28 at $500M; LTC 2026-06-30 at $300M; ONclick Healthcare 2026-05-06 at $3M; PureSpectrum 2026-01-06 undisclosed; Genelux 2025-03-25 at $11M). Named stages also recur, including Seed (Cognify is undisclosed, while Genstore is Seed at $10M on 2025-09-27) and AI-related Series rounds such as inVia Robotics (Series C, $30M on 2021-07-28).
Are there notable small-end or low-disclosure outliers you would flag for diligence?
At the small end, Southeast Ventura County YMCA reports $100K (Grant, 2021-12-02), which is the smallest disclosed amount in the list. At the same time, the top of the table includes multiple undisclosed amounts close to the present date (Cognify on 2026-07-13 and PureSpectrum on 2026-01-06), which can signal diligence needs when comparing deal size and traction.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.